AzTrials
AzTrials

Diastasis Recti AbdominisNCT07805915

Prospective One-Year Evaluation of the Safety and Effectiveness of an Investigator-Developed Rectus Abdominis Plication Technique in Abdominoplasty

A study testing Investigator-Developed Rectus Abdominis Plication and Standardized Abdominal Wall Ultrasound in people with Diastasis Recti Abdominis and Abdominal Wall Laxity, run by Research Inc at 1 site in Colombia.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This prospective single-group study will evaluate an investigator-developed rectus abdominis plication performed during abdominoplasty. Standardized ultrasound will measure inter-rectus distance before surgery and at 3 and 12 months. The primary outcome is change in mean inter-rectus distance at one year. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Investigator-Developed Rectus Abdominis Plication and Standardized Abdominal Wall Ultrasound
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteColombia
Study dates
12 Jan 2024to 1 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 to 65 years.
  • Scheduled for primary abdominoplasty with rectus plication.
  • Rectus diastasis documented clinically or by baseline ultrasound.
  • Stable body weight for at least 3 months before surgery.
  • Ability to complete ultrasound and clinical follow-up through 12 months.
  • Written informed consent.

Who cannot join

  • Prior major abdominal wall reconstruction or mesh repair that prevents standardized plication assessment.
  • Ventral or incisional hernia requiring a separate reconstructive procedure.
  • Pregnancy, breastfeeding, or planned pregnancy during the 12-month follow-up.
  • Uncontrolled systemic disease or contraindication to elective abdominoplasty.
  • BMI greater than 35 kg/m2 unless the final operative protocol intentionally includes this population.
  • Inability to obtain technically adequate baseline ultrasound measurements.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

jose D Salazar, MD, Plastic surgeon contact

+57 311 6058486

heimdal007@gmail.com

Colombia1 site, 1 recruiting
  • IQ interquirofanos

    Medellín

    Jose D Salazar, MD, Plastic surgeon, +57 311 6058486, heimdal007@gmail.com

    Recruiting

Other trials in Colombia

About this study

This prospective single-group study will evaluate an investigator-developed rectus abdominis plication performed during abdominoplasty. Standardized ultrasound will measure inter-rectus distance before surgery and at 3 and 12 months. The primary outcome is change in mean inter-rectus distance at one year. Recurrence, abdominal wall function, BODY-Q satisfaction, surgical complications, and reoperation will also be assessed.

Read the detailed description

Adults undergoing primary abdominoplasty with rectus diastasis will receive a standardized plication described in a locked operative manual. Baseline and postoperative ultrasound will measure the inter-rectus distance at three fixed abdominal levels. Operative variables and protocol adherence will be recorded. Follow-up visits through month 12 will assess anatomical durability, recurrence, abdominal wall function, patient-reported satisfaction, and complications. The study is designed to generate reproducible one-year safety and effectiveness estimates and to identify factors associated with recurrence.

Being tested
Investigator-Developed Rectus Abdominis Plication, Standardized Abdominal Wall Ultrasound
Keywords
Abdominoplasty, Rectus Abdominis Plication, Diastasis Recti, Ultrasound, Abdominal Wall Function, Recurrence
Medical subject headings
Recurrence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Investigator-Developed Rectus Abdominis PlicationProcedure or surgery

    A standardized plication is performed during abdominoplasty. The locked operative appendix will specify patient position, exposure, cranial and caudal limits, suture material, number of layers, stitch configuration, target tension, intraoperative measurements, and management of associated hernia if permitted. Linked arm/group(s): Investigator-Developed Rectus Plication.

  • Standardized Abdominal Wall UltrasoundDiagnostic test

    Inter-rectus distance will be measured at fixed levels during a standardized respiratory phase and abdominal muscle state. Three measurements per level will be averaged by a trained assessor. Linked arm/group(s): Investigator-Developed Rectus Plication.

Study groups in NCT07805915
Study groupRoleWhat they receive
Investigator-Developed Rectus PlicationExperimentalParticipants undergo abdominoplasty with the standardized investigator-developed plication and complete one-year anatomical, functional, and safety follow-up.
Receives: Procedure: Investigator-Developed Rectus Abdominis Plication; Diagnostic Test: Standardized Abdominal Wall Ultrasound
abdominoplasty with linear rectus plicationActive comparatorParticipants undergo abdominoplasty with linear rectus plication the standardized control; investigator-perform plication and complete one-year anatomical, functional, and safety follow-up.
Receives: Diagnostic Test: Standardized Abdominal Wall Ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Mean waist perimeter

    waist perimeter in cm will be measured by a meter at fixed supraumbilical levels. Change is 12-month minus baseline distance; a more negative value indicates greater narrowing.

    Measured: Baseline and postoperative month 12. 12 months

Secondary outcomes (4)
  1. Incidence of Plication-Related Major Complications

    Proportion of participants with abdominal compartment symptoms requiring intervention, plication disruption, symptomatic recurrence, reoperation, thromboembolic event, respiratory compromise attributed to increased abdominal pressure, or other serious event adjudicated as related to plication.

    Measured: From surgery through postoperative month 12.

  2. Change in Abdominal Wall Physical Function

    Change in the selected validated abdominal/core function instrument or BODY-Q Physical Function score. The final instrument and scoring rules will be locked before enrollment.

    Measured: Baseline, postoperative month 3, and postoperative month 12.

  3. Change in BODY-Q Abdomen Satisfaction Score

    Rasch-transformed 0-to-100 BODY-Q Abdomen score; higher values indicate greater satisfaction with abdominal appearance. Use requires the appropriate license and authorized translation.

    Measured: Baseline, postoperative month 6, and postoperative month 12.

  4. Incidence of Standard Abdominoplasty Complications

    Proportion with seroma requiring aspiration, hematoma, surgical-site infection, wound dehiscence, skin necrosis, venous thromboembolism, or unplanned reoperation.

    Measured: From surgery through postoperative day 30. 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Sep 2026
  2. Study start12 Jan 2024
  3. Primary completion1 Sep 2026
  4. Study completion1 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07805915
Sponsor's protocol ID
011
Status last verified
Oct 2026
First submitted
1 Sep 2026
Last updated
7 Oct 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: no contemplated in the patient informed consent

Publications

  • Amro C, Ryan IA, Jog A, Broach RB, Fischer JP, Altieri MS, Azoury SC. Outcomes of Abdominal Contouring in Patients with and without Weight Loss Surgery: A Propensity-Matched Comparison Study. Plast Reconstr Surg. 2026 Mar 1;157(3):464-473. doi: 10.1097/PRS.0000000000012384. Epub 2025 Aug 13.

    PubMed 40801412
  • Swanson E. Abdominal Fascial Plication and the Risk of Venous Thromboembolism in Abdominoplasty Patients: A Systematic Review of the Literature. Ann Plast Surg. 2025 Mar 1;94(3):378-383. doi: 10.1097/SAP.0000000000004149. Epub 2024 Nov 6.

    PubMed 39774064
  • Restifo RJ. An In-Depth Analysis of 1370 Consecutive Abdominoplasties: Fascial Plication Increases Risk of Venous Thromboembolism, and Scoring for Plication Improves the Caprini Risk Assessment Model. Aesthet Surg J. 2024 Nov 15;44(12):NP870-NP882. doi: 10.1093/asj/sjae139.

    PubMed 38967610
  • Marchica P, Costa AL, Brambullo T, Marini M, Masciopinto G, Gardener C, Grigatti M, Bassetto F, Vindigni V. Retrospective Analysis of Predictive Factors for Complications in Abdominoplasty in Massive Weight Loss Patients. Aesthetic Plast Surg. 2023 Aug;47(4):1447-1458. doi: 10.1007/s00266-022-03235-5. Epub 2023 Jan 6.

    PubMed 36609741
  • Staalesen T, Olsen MF, Elander A. The Effect of Abdominoplasty and Outcome of Rectus Fascia Plication on Health-Related Quality of Life in Post-Bariatric Surgery Patients. Plast Reconstr Surg. 2015 Dec;136(6):750e-761e. doi: 10.1097/PRS.0000000000001772.

    PubMed 26595030
  • Wilting R, Lier B, de Vries CE, Dalaei F, Poulsen L, Luketina R, Repo JP, Paul M, Hoogbergen M; BODY-Q Network. Health-Related Quality-of-Life Effects of Rectus Repair during Body Contouring Surgery in Postbariatric Patients: A Prospective Study. Plast Reconstr Surg. 2024 Oct 1;154(4):735-745. doi: 10.1097/PRS.0000000000011168. Epub 2023 Oct 30.

    PubMed 37903329

Questions about this trial

What is this clinical trial studying?

A study testing Investigator-Developed Rectus Abdominis Plication and Standardized Abdominal Wall Ultrasound in people with Diastasis Recti Abdominis and Abdominal Wall Laxity, run by Research Inc at 1 site in Colombia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Colombia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact jose D Salazar, MD, Plastic surgeon (+57 311 6058486, heimdal007@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Mean waist perimeter (time frame: Baseline and postoperative month 12. 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07805915, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in